Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AB Science provides an update on the development of masitinib in progressive…
PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024Paris, 23 September 2024, 5.45pm CETAB Science SA(Euronext - FR0010557264 - AB) today provides an update on the development of masitinib in progressive forms of multiple sclerosis (MS), following the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 conference.The development of masitinib in progressive forms of...
Nasdaq GlobeNewswire
23/09/2024
Casino Group: Creation of the Aura Retail alliance
PRESS RELEASE 23 September 2024 Creation of the Aura Retail alliance:Intermarché, Auchan and Casino set up long-termpurchasing partnershipIntermarché, Auchan and Casino 1have cemented their long-term purchasing partnership with the creation of the Aura Retail alliance...
Nasdaq GlobeNewswire
23/09/2024
Medical Electrodes Market Surges to USD 25.6 Billion by 2030, Propelled by…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=32304 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=32304 Browse in-depth TOC on Medical Electrodes Market 202 – Pages 126 – Tables 37 – Figures Scope of The Report Global Medical Electrodes Market Overview Market Drivers Fueling Growth in the Medical Electrodes Market Rising Incidence of Chronic Diseases The increasing prevalence...
PR Newswire
23/09/2024
HUBLOT AND SORAI UNITED FOR CHANGE
But by being United for Change, there is good news. Conservation programmes such as those supported by SORAI have helped increase the population of Indian rhinos from around 200 at the turn of the 20th century to around 4,000 today, while black rhinos have doubled in number over the past two decades. Hublot is proud to support SORAI as it empowers conservation agencies to continue this work and bring positive change. But by being United for Change, there is good news. Conservation programmes...
PR Newswire
23/09/2024
Sterilization Services Market to Hit USD 5.2 Billion by 2029 with 7.7% CAGR |…
Browse in-depth TOC on "Sterilization Services Market" Browse in-depth TOC on "Sterilization Services Market" 287 - Tables38 - Figures249 - Pages The global sterilization services market is divided into five segments based on method: ethylene oxide sterilization, gamma sterilization, electron beam sterilization, x-ray irradiation sterilization, steam sterilization, hydrogen peroxide sterilization and other methods. With the most market share in 2023, the sterilization...
PR Newswire
23/09/2024
Animal Antibacterial and Antibiotics Market Poised for Significant Growth…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=211662 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=211662 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Animal Antibacterial and Antibiotics Market Overview Geographic Dominance : The geographic dominance of the bike-sharing market is led byAsia-Pacific,Europe, andNorth America.Asia-Pacificholds the largest market...
PR Newswire
23/09/2024
Laboratory Information System Market Surges to USD 3.6 Billion by 2030…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817200 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817200 Browse in-depth TOC onLaboratory Information System Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Laboratory Information System Market Overview Market Drivers Fueling Growth in the Laboratory Information System Market Increasing Demand for Automation in...
PR Newswire
23/09/2024
LILYSILK Unveils Winter 2024 Collection "Rustic Retreat," A Celebration of…
A Rustic Escape through Fashion A Rustic Escape through Fashion The "Rustic Retreat" collection encapsulates the essence of a peaceful, countryside haven where simplicity meets sophistication. From flowing silk maxi skirts to textured cashmere cardigans, each piece reflects LILYSILK's dedication to quality, sustainability, and elegance. Premium Designs for Timeless Appeal LILYSILK's attention to detail and craftsmanship shine through the collection's unique, premium designs,...
PR Newswire
23/09/2024
Jackson Health System projects 47% reduction in carbon emissions from patient…
Opportunity for significant savings in energy consumption, reduction of paper and elimination of disposable batteries for telemetry revealed in Life Cycle Assessment Amsterdam, The Netherlands and Cambridge, Mass. and Miami, FL. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Jackson Health System, one of the nation's largest public health systems in the United States, today announced results of a collaborative Life Cycle Assessment (LCA) measuring...
Nasdaq GlobeNewswire
23/09/2024
Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of…
/13 (CDK12/13) inhibitor / Cyclin-K glue-degrader. CDK12/13 is implicated in multiple cancer types, as they regulate transcription elongation, RNA splicing, as well as cleavage and polyadenylation. DNA damage response genes are particularly suppressed by loss of CDK12/13 activity. The clinical trial is enrolling patients with advanced solid tumors, including ovarian, breast and Ewing's Sarcoma. "Initiation of our CT7439 Phase 1 clinical trial marks the advancement of our second…
Nasdaq GlobeNewswire
23/09/2024
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b…
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept.23, 2024(GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in...
Nasdaq GlobeNewswire
23/09/2024
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 23 September 2024– On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under…
Nasdaq GlobeNewswire
23/09/2024
Ipsen's Kayfanda® (odevixibat) approved in European Union for cholestatic…
Kayfanda ®(odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare liver condition, Alagille SyndromeE.U. marketing authorization for Kayfanda based on data from ASSERT the only Phase III trial completed in patients with Alagille SyndromeKayfanda approval for use in the E.U. further expands Ipsen's rare cholestatic liver disease portfolio ...
Nasdaq GlobeNewswire
23/09/2024
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment…
uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to AMT-191, uniQure's investigational gene therapy for the treatment of Fabry disease, a rare, inherited genetic disease. In August 2024, uniQure announced the dosing of the first patient in its U.S., multi-center, open-label Phase I/IIa trial of AMT-191...
Nasdaq GlobeNewswire
23/09/2024
Wet Shave Market to Reach $46.8 Million, Globally, by 2033 at 9.9% CAGR: Allied…
Request The Sample PDF of This Report: @ https://www.alliedmarketresearch.com/request-sample/A07780 Request The Sample PDF of This Report: @https://www.alliedmarketresearch.com/request-sample/A07780 Prime determinants of growth One of the main factors driving the wet shave market's expansion is rising consumer awareness of personal grooming, which is being fueled by social media's influence and shifts in culture. Technological developments in razor and shaving product designs...
PR Newswire
23/09/2024
Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for…
"Our academic research centre has been at the forefront of evaluating the impact of HOPE in several aspects of liver transplantation," said Dr Damiano Patrono, MD, Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino, Italy and principal investigator of the three trials. "We continue to be impressed with the value that the use of HOPE brings to increasing the supply of available livers for transplantation, potentially improving access for those in need of livers…
PR Newswire
23/09/2024
3B Scientific Acquires Veterinary Simulator Industries
David Jackson, Managing Director of Veterinary Simulator Industries, added: "Joining forces with 3B Scientific is an exciting step forward for VSI. The global reach of the 3B Scientific Group and commitment to innovation will enable us to further develop our product line and deliver even greater value to the veterinary education community. Together, we look forward to creating more advanced, realistic simulators and expanding access to high-quality training tools." David Jackson…
PR Newswire
23/09/2024
Buyback of Class B shares in Essity during week 38, 2024
The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
23/09/2024
Professor Luo Min Invited to Attend World Congress on Cardiology and Heart…
Professor Luo discovered that spinal nerve abnormalities can lead to spasms, contractions, and narrowing of the coronary arteries, resulting in myocardial ischemia. He emphasized that abnormal thoracic sympathetic nerve function, often overlooked, plays a key role in coronary heart disease. Since the coronary arteries are controlled by these nerves, excessive nerve activity can cause artery contractions. Therefore, regulating the nervous system may relieve coronary spasms and stenosis, offering…
PR Newswire
23/09/2024
Mölnlycke and Ondine join forces against HAIs
This collaboration marks a significant milestone in the fight against healthcare-associated infections (HAIs) and the growing threat of antimicrobial resistance (AMR), as Steriwave safely reduces hospital infections without generating AMR. Steriwave, a non-antibiotic, light-activated nasal decolonisation therapy, has been clinically proven1-5 to reduce harmful pathogens in the nasal passages, a common source of HAIs and cause of higher rates of mortality, length of stay and readmissions…
PR Newswire
23/09/2024
Biocomposites to showcase innovations in infection management at EBJIS 2024
The Biocomposites-sponsored symposium, to take place on September 27, is titled "Improving outcomes in complex PJI cases". It will include expert presentations on the aggregation of marginal gains in infection management and optimising intraoperative protocols to combat challenging infections. The symposium will be chaired by Mr Pedro Foguet (Consultant Orthopaedic & Trauma Surgeon), who will be joined by Prof Lee Jeys (Consultant Orthopaedic Surgeon) and Mr Abtin Alvand…
PR Newswire
23/09/2024
Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1…
Vicebio has recently initiated a Phase I clinical trial with VXB-241, its bivalent vaccine targeting both RSV and hMPV viruses that cause a significant burden of disease in elderly patients and those with a weakened immune system. There is currently no commercially available vaccine targeting RSV and hMPV. Initial clinical readouts of the Phase 1 study are expected mid 2025. This financing will also support the acceleration and expand further development of Vicebio's multivalent pipeline…
PR Newswire
23/09/2024
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform…
Relatable™ is a Product Relationship Management (PRM) platform created for medtech manufacturers and distributors to unlock new competitive conversion capabilities that drive cost-efficient revenue growth. The platform establishes a single source of truth for all information associated with specific products and their direct competitors, populating a data management platform available to contracting, sales, marketing and technical support teams. Relatable™ is a Product Relationship Management...
PR Newswire
23/09/2024
VITALOGRAPH ACQUIRES MORGAN SCIENTIFIC TO MEET GROWING GLOBAL DEMAND FOR…
Speaking of the acquisition,Frank Keane, CEO of Vitalograph said: "We have a long and successful relationship with Morgan Scientific. This agreement is the natural progression for both companies as our combined expertise allows us to focus on delivering the best possible diagnostic solutions that can enable a better understanding of lung health." Morgan Scientific is an expert in customer-facing software for advanced PFT systems. ComPAS2, the company's flagship software powers...
PR Newswire
23/09/2024
Altri Comunicati
